Meeting
2020 Gastrointestinal Cancers Symposium
Impact of antibiotic exposure on the efficacy of immune checkpoint blockade in MSI-H metastatic CRC.
Authors
Victoria Serpas
MD Anderson Cancer Center Hematology/Oncology Fellowship, Houston, TX
Victoria Serpas , Jane Elizabeth Rogers , Lianchun Xiao , Kerri Mola-Rudd , Arvind Dasari , Bryan K. Kee , Michael J. Overman , Benny Johnson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 161)
Abstract #
161
Poster Bd #
H3
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).
First Author: Charlee Nardin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Initial findings from the DREAM-GI national database: Assessing the efficacy and safety of neoadjuvant immunotherapy (NIT) in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) gastrointestinal (GI) cancer.
First Author: Sakti Chakrabarti
Poster
2023 ASCO Quality Care Symposium
Uptake and efficacy of immuno-oncology combinations in metastatic renal cell carcinoma in the United States: Evidence from the ASCO CancerLinQ Discovery database.
First Author: Joseph Vento
Poster
2021 ASCO Annual Meeting
Patient and treatment characteristics of emergency presentations due to immune-mediated toxicities.
First Author: Sharon Hyo-Eun Nahm